#pharmaceuticalindustry — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pharmaceuticalindustry, aggregated by home.social.
-
West Pharmaceutical hit by cyberattack, data stolen
West Pharmaceutical Services suffered a significant cybersecurity breach on May 4, 2026, when hackers infiltrated their systems, encrypting certain data and making off with sensitive information, prompting a formal investigation. The company confirmed the severity of the attack three days later, on May 7.
#PharmaceuticalIndustry #CybersecurityAttack #DataExfiltration #Ransomware #EmergingThreats
-
https://www.europesays.com/dk/81734/ Zacks Investment Ideas feature highlights Eli Lilly, Novo, JP Morgan, Coca-Cola, PepsiCO and Mondelez #AmericanBeachPhoto #EliLilly #JPMorganJPM #NovoNordisk #ObesityEpidemic #PepsiCo #PharmaceuticalIndustry #WeightLoss #WeightLossDrugs
-
https://www.europesays.com/videos/20857/ Thailand’s monkey business: Pharmaceutical labs rely on primate testing • FRANCE 24 English #AnimalCruelty #Animals #FRANCE24 #FRANCE24English #FRANCE24 #FRANCE24English #labs #macaques #monkeys #pharma #PharmaceuticalIndustry #testing #Thailand #TRAFFICKING
-
Man’s GLP-1 Horror Story Leads to Organ Removal
A man who lost over 80 pounds before nearly losing his life is sharing his story as a…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #beauty #Diabetes #drug #GLP-1 #GLP-1s #looker #men'sgrooming #Ozempic #Pharmaceuticaldrug #pharmaceuticalindustry #TheLooker #weightloss
https://www.newsbeep.com/us/612155/ -
Man’s GLP-1 Horror Story Leads to Organ Removal
A man who lost over 80 pounds before nearly losing his life is sharing his story as a…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #beauty #Diabetes #drug #GLP-1 #GLP-1s #looker #men'sgrooming #Ozempic #Pharmaceuticaldrug #pharmaceuticalindustry #TheLooker #weightloss
https://www.newsbeep.com/us/612155/ -
https://www.europesays.com/africa/200447/ Malaysia shares healthcare expertise with Namibia #CapacityBuilding #HealthDiplomacy #Malaysia #MedicalTourism #MedicineSupply #Namibia #PharmaceuticalIndustry #PublicHealth #SustainableHealthcare #UniversalHealthCoverage
-
MOH Moves To ‘Optimise’ Drug Dispensing As Supply Risks Loom
KUALA LUMPUR, April 2 — The Ministry of Health (MOH) is tightening medicine dispensing in public hospitals as…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Health #MinistryofHealth #pharmaceuticalindustry #PharmaceuticalServicesProgramme(PSP) #supplychain #WestAsiaconflict
https://www.newsbeep.com/us/563651/ -
MOH Moves To ‘Optimise’ Drug Dispensing As Supply Risks Loom
KUALA LUMPUR, April 2 — The Ministry of Health (MOH) is tightening medicine dispensing in public hospitals as…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Health #MinistryofHealth #pharmaceuticalindustry #PharmaceuticalServicesProgramme(PSP) #supplychain #WestAsiaconflict
https://www.newsbeep.com/us/563651/ -
https://www.europesays.com/ie/?p=419502 MOH Moves To ‘Optimise’ Drug Dispensing As Supply Risks Loom #Éire #Health #IE #Ireland #Medication #MinistryOfHealth #PharmaceuticalIndustry #PharmaceuticalServicesProgramme(PSP) #SupplyChain #WestAsiaConflict
-
https://www.europesays.com/uk/867240/ MOH Moves To ‘Optimise’ Drug Dispensing As Supply Risks Loom #Health #Medication #MinistryOfHealth #PharmaceuticalIndustry #PharmaceuticalServicesProgramme(PSP) #SupplyChain #UK #UnitedKingdom #WestAsiaConflict
-
How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures
A bioprocess engineer's journey into machine learning and why the pharmaceutical industry desperately needs this bridge When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. What I don't usually mention is that I've been teaching myself machine learning on nights and weekends. Not because it's trendy, but […] -
From Bioreactors to AI: How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures
*A bioprocess engineer's journey into machine learning—and why the pharmaceutical industry desperately needs this bridge* --- When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. The $50 Million Problem Nobody Talks About What I don't usually mention is that I've been teaching myself machine learning […] -
From Bioreactors to AI: How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures
*A bioprocess engineer's journey into machine learning—and why the pharmaceutical industry desperately needs this bridge* --- When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. The $50 Million Problem Nobody Talks About What I don't usually mention is that I've been teaching myself machine learning […] -
Gender and geographic disparities among DSM-5-TR authors in relation to financial conflicts of interest and industry payments: cross-sectional analysis: New analysis of undisclosed pharmaceutical company money 💰💊 to the "bible" of psychiatry 📖🧠
Read Full Article
#GenderDisparities #GeographicDisparities #DSM5TR #FinancialConflicts #PharmaceuticalIndustry https://mentalhealth.bmj.com/content/28/1/e301913
Reenviado desde Science News
(https://t.me/experienciainterdimensional/9576) -
Mark Cuban Would Still Have Dinner With Donald Trump
-
Donald Trump’s Big Pharma Showdown Ends with a Whimper
-
Amgen Inc. will invest over $600 million to build a new R&D center in California, aiming to boost innovation and create hundreds of U.S. jobs amid rising domestic pharmaceutical investment.
#YonhapInfomax #Amgen #RDCenter #Investment #California #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=79978 -
Amgen Inc. will invest over $600 million to build a new R&D center in California, aiming to boost innovation and create hundreds of U.S. jobs amid rising domestic pharmaceutical investment.
#YonhapInfomax #Amgen #RDCenter #Investment #California #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=79978 -
Amgen Inc. will invest over $600 million to build a new R&D center in California, aiming to boost innovation and create hundreds of U.S. jobs amid rising domestic pharmaceutical investment.
#YonhapInfomax #Amgen #RDCenter #Investment #California #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=79978 -
Amgen Inc. will invest over $600 million to build a new R&D center in California, aiming to boost innovation and create hundreds of U.S. jobs amid rising domestic pharmaceutical investment.
#YonhapInfomax #Amgen #RDCenter #Investment #California #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=79978 -
Yuhan Corp. celebrates its 99th anniversary, unveiling plans to become a global top 50 pharmaceutical company through enhanced R&D and sustainable management.
#YonhapInfomax #YuhanCorp #99thAnniversary #PharmaceuticalIndustry #Leclaza #GlobalExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68545 -
https://www.europesays.com/uk/123554/ New drug prices for rare diseases are increasing sharply #DrugPricing #Health #medical #Medication #MedicationCosts #Netflix #OrphanDrug #pharma #PharmaceuticalIndustry #PharmaceuticalsPolicy #pharmacy #Quartz #SocialIssues #SpecialtyDrugsInTheUnitedStates #TinglongDai #UK #UnitedKingdom
-
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037 -
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037 -
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037 -
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037 -
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037 -
Doximity's stock plummets 14% despite strong Q1 results, as Q2 guidance falls short of expectations amid policy uncertainties in the pharmaceutical industry.
#YonhapInfomax #Doximity #Q1Earnings #StockPlunge #GuidanceDisappointment #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63653 -
Trump announces executive order to drastically cut prescription drug prices by 30-80%, aiming for global price parity and U.S. market fairness
#YonhapInfomax #TrumpExecutiveOrder #PrescriptionDrugPrices #PharmaceuticalIndustry #HealthcareReform #DrugPriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62722 -
Trump promises significant and immediate reduction in drug prices, potentially reshaping pharmaceutical industry and healthcare costs
#YonhapInfomax #TrumpStatement #DrugPrices #HealthcareReform #PharmaceuticalIndustry #PriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62713 -
Trump promises significant and immediate reduction in drug prices, potentially reshaping pharmaceutical industry and healthcare costs
#YonhapInfomax #TrumpStatement #DrugPrices #HealthcareReform #PharmaceuticalIndustry #PriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62713 -
Trump promises significant and immediate reduction in drug prices, potentially reshaping pharmaceutical industry and healthcare costs
#YonhapInfomax #TrumpStatement #DrugPrices #HealthcareReform #PharmaceuticalIndustry #PriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62713 -
Trump promises significant and immediate reduction in drug prices, potentially reshaping pharmaceutical industry and healthcare costs
#YonhapInfomax #TrumpStatement #DrugPrices #HealthcareReform #PharmaceuticalIndustry #PriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62713 -
Trump promises significant and immediate reduction in drug prices, potentially reshaping pharmaceutical industry and healthcare costs
#YonhapInfomax #TrumpStatement #DrugPrices #HealthcareReform #PharmaceuticalIndustry #PriceReduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62713 -
Celltrion reports Q1 operating profit surge of 868% to 149.4 billion won, driven by strong sales of follow-up products and improved cost efficiency post-merger
#YonhapInfomax #Celltrion #Q1Earnings #OperatingProfit #Biosimilars #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62540 -
SK Biopharm reports Q1 operating profit of 25.7 billion won, up 149% year-on-year but below market expectations, with sales rising 26.7% to 144.4 billion won
#YonhapInfomax #SKBiopharm #Q1Earnings #OperatingProfit #MarketExpectations #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62439 -
SK Biopharmaceuticals reports Q1 operating profit surge of 149% to 25.7 billion won, falling short of market expectations despite significant growth
#YonhapInfomax #SKBiopharmaceuticals #Q1Earnings #OperatingProfit #PharmaceuticalIndustry #FinancialPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62437 -
Gilead Sciences announces $11 billion additional investment in US amid tariff pressure, aiming to boost domestic manufacturing and R&D capabilities by 2030
#YonhapInfomax #GileadSciences #USInvestment #PharmaceuticalIndustry #TariffPolicies #DomesticProduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62277 -
Yuhan Corporation reports Q1 operating profit of 8.6 billion won, falling short of market expectations despite year-on-year growth, as sales reach 469.4 billion won
#YonhapInfomax #YuhanCorporation #Q1Earnings #OperatingProfit #MarketExpectations #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62246 -
Celltrion explores US-based API production facilities to mitigate potential Trump administration drug tariffs, implements short-term inventory transfer and medium-term local production strategies.
#YonhapInfomax #Celltrion #DrugTariffs #APIProduction #USManufacturing #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61960 -
Goldman Sachs adds Johnson & Johnson to its May 'Conviction List', citing stable growth and strong financials, with 10% upside potential amid robust drug pipeline
#YonhapInfomax #GoldmanSachs #JohnsonAndJohnson #ConvictionList #PharmaceuticalIndustry #StockRecommendation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61511 -
Hanmi Pharmaceutical reports Q1 operating profit of 59 billion won, meeting market expectations despite year-on-year declines in sales and profit
#YonhapInfomax #HanmiPharmaceutical #Q1Earnings #OperatingProfit #MarketExpectations #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60949 -
Chong Kun Dang maintains financial stability through cash flow management and portfolio diversification, despite sales challenges from product terminations and market volatility.
#YonhapInfomax #ChongKunDang #FinancialManagement #PharmaceuticalIndustry #ProductPortfolio #CashFlowManagement #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59333 -
Hanmi Science CEO Kim Jae-gyo announces focus on innovative global drug development, restructures organization to enhance strategic growth and innovation capabilities
#YonhapInfomax #HanmiScience #GlobalNewDrugs #PharmaceuticalIndustry #OrganizationalRestructuring #InnovationStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56769 -
US pharmaceutical giants face potential tariff risks as Trump administration considers imposing up to 25% tariffs on imported drugs, with Merck, AbbVie, Amgen, and Pfizer identified as most vulnerable.
#YonhapInfomax #TrumpTariffs #PharmaceuticalIndustry #Merck #AbbVie #ImportedDrugs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56730 -
President Trump signals openness to tariff negotiations after reciprocal tariff announcement, highlighting potential for trade talks while maintaining stance on historical trade imbalances.
#YonhapInfomax #Trump #ReciprocalTariffs #TradeNegotiations #USTradePolicy #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56183 -
Celltrion re-elects founder Seo Jung-jin as internal director, highlighting his role in driving innovation and growth in the pharmaceutical industry
#YonhapInfomax #Celltrion #SeoJungJin #InternalDirector #PharmaceuticalIndustry #Biosimilars #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=55540 -
US tariffs present dual threat for EU economy, health economists warn on pharma impact https://www.euractiv.com/section/health-consumers/news/us-tariffs-present-dual-threat-for-eu-economy-health-economists-warn-on-pharma-impact/?utm_source=dlvr.it&utm_medium=mastodon #Bigpharma #EUPharmaPackage #pharmaceuticalindustry #tariffs
